Cleared Traditional

K962019 - C-REACTIVE PROTEIN (CRP):A LATEX SLIDE TEST

K962019 is an FDA 510(k) clearance for C-REACTIVE PROTEIN (CRP):A LATEX SLIDE TEST, manufactured by Teco Diagnostics. The device is a Class 2 Immunology device with product code DCK cleared through the Traditional 510(k) pathway after a 186-day FDA review.

K962019 · Teco Diagnostics · Immunology device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Nov 1996
Decision
186d
Days
Class 2
Risk

K962019 is an FDA 510(k) clearance for the C-REACTIVE PROTEIN (CRP):A LATEX SLIDE TEST. Classified as C-reactive Protein, Antigen, Antiserum, And Control (product code DCK), Class II - Special Controls.

Submitted by Teco Diagnostics (Placentia, US). The FDA issued a Cleared decision on November 25, 1996 after a review of 186 days - an extended review cycle.

This device falls under the Immunology FDA review panel, regulated under 21 CFR 866.5270 - the FDA immunology device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Standard predicate-based submission. Standard predicate reliance. This clearance follows a standard predicate-based equivalence path within the Immunology review framework, consistent with the majority of Class II 510(k) submissions.

View all Teco Diagnostics devices

FDA 510(k) Submission Details - K962019

510(k) Number K962019 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received May 23, 1996
Decision Date November 25, 1996
Days to Decision 186 days
Submission Type Traditional
Review Panel Immunology (IM)
Summary Statement
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
82d slower than avg
Panel avg: 104d · This submission: 186d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

DCK Device Classification - Class 2, Special Controls

Product Code DCK C-reactive Protein, Antigen, Antiserum, And Control
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 866.5270
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Immunology devices follow this clearance model.

Regulatory Peers - DCK C-reactive Protein, Antigen, Antiserum, And Control

All 94
Devices cleared under the same product code (DCK) and FDA review panel - the closest regulatory comparables to K962019.
CRP-LEX SYSTEM: C-REACTIVE PROTEIN ANTIGEN DETECTION IN SERUM: SLIDE AGGLUTNATION LATEX TEST
K972160 · Trinity Laboratories, Inc. · Aug 1997
N-ASSAY TIA MULTI CRP CALIBRATOR SET
K965110 · Crestat Diagnostics, Inc. · Jul 1997
C-REACTIVE PROTEIN (CRP) AGGLUTINATION LATEX KIT
K962049 · Polymedco, Inc. · Dec 1996
IMMAGE IMMUNOCHEMISTRY SYSTEM C-REACTIVE PROTEIN (CRP) REAGENT
K963061 · Beckman Instruments, Inc. · Nov 1996
QUALITROL CRP CONTROL SET
K961829 · Consolidated Technologies, Inc. · Aug 1996
N/T RHEUMATOLOGY CONTROL SL/1 AND SL/2
K962373 · Behring Diagnostics, Inc. · Jul 1996